Diffuse pulmonary hemorrhage: Clues to the diagnosis

Current Problems in Diagnostic Radiology

Volumn 43, Issue 3, 2014, Pages 128-139

  Lichtenberger, John P ^a   Digumarthy, Subba R ^a   Abbott, Gerald F ^a   Shepard, Jo Anne O ^a   Sharma, Amita ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; AMIODARONE; ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CARBIMAZOLE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; FRESH FROZEN PLASMA; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NITROFURANTOIN; PENICILLAMINE; PHENYTOIN; PREDNISONE; PROPYLTHIOURACIL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB;

ANEMIA; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC PULMONARY VENOUS HYPERTENSION; CHURG STRAUSS SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIFFUSE PULMONARY HEMORRHAGE; DRUG MEGADOSE; GOODPASTURE SYNDROME; HEMOPTYSIS; HUMAN; IDIOPATHIC PULMONARY HEMORRHAGE; KIDNEY DISEASE; LUNG DISEASE; LUNG EDEMA; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG HEMOSIDEROSIS; MICROSCOPIC POLYANGIITIS; PLASMAPHERESIS; PLEURA EFFUSION; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY RENAL SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS; COMPLICATION; COUGHING; DISEASE COURSE; FEVER; HEMORRHAGE; INTERSTITIAL LUNG DISEASE; LUNG; LUNG LAVAGE; PATHOLOGY; RADIOGRAPHY;

BRONCHOALVEOLAR LAVAGE; COUGH; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEVER; HEMOPTYSIS; HEMORRHAGE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899699619     PISSN: 03630188     EISSN: 15356302     Source Type: Journal    
DOI: 10.1067/j.cpradiol.2014.01.002     Document Type: Article

References (47)

1. Zamora M.R., Warner M.L., Tuder R., et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997, 76(3):192-202.
2. Schwarz M.I., Mortenson R.L., Colby T.V., et al. Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation. Am Rev Respir Dis 1993, 148(2):507-511.
3. Hunt D.P., Weil R., Nicholson A.G., et al. Pulmonary capillaritis and its relationship to development of emphysema in hypocomplementaemic urticarial vasculitis syndrome. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23(1):70-72.
4. Lara A.R., Schwarz M.I. Diffuse alveolar hemorrhage. Chest 2010, 137(5):1164-1171.
5. Albelda S.M., Gefter W.B., Epstein D.M., et al. Diffuse pulmonary hemorrhage: a review and classification. Radiology 1985, 154(2):289-297.
6. Travis W.D., Colby T.V., Lombard C., et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990, 14(12):1112-1125.
7. Stone J.H. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum 2003, 48(8):2299-2309. Wegener's Granulomatosis Etanercept Trial Research Group.
8. Cordier J.F., Valeyre D., Guillevin L., et al. Wegener[U+05F3]s granulomatosis: a clinical and imaging study of 77 cases. Chest 1990, 97:906-912.
9. Lee K.S., Kim T.S., Fujimoto K., et al. Thoracic manifestation of Wegener[U+05F3]s granulomatosis: CT findings in 30 patients. Eur Radiol 2003, 13:43-51.
10. Sheehan R.E., Flint J.D.A., Müller N.L. Computed tomography features of thoracic manifestations of Wegener granulomatosis. J Thorac Imaging 2003, 18:34-41.
11. van der Woude F.J., Rasmussen N., Lobatto S., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener[U+05F3]s granulomatosis. Lancet 1985, 1(8426):425-429.
12. Travis W.D., Colby T.V., Koss M.N., et al. Nonneoplastic Disorders of the Lower Respiratory Tract 2002, 233-264. Armed Forces Institute of Pathology, Washington, DC.
13. Travis W.D., Carpenter H.A., Lie J.T. Diffuse pulmonary hemorrhage. An uncommon manifestation of Wegener[U+05F3]s granulomatosis. Am J Surg Pathol 1987, 11(9):702-708.
14. Keogh K.A., Ytterberg S.R., Fervenza F.C., et al. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006, 173(2):180-187.
15. Sugimoto T., Deji N., Kume S., et al. Pulmonary-renal syndrome, diffuse pulmonary hemorrhage and glomerulonephritis, associated with Wegener's granulomatosis effectively treated with early plasma exchange therapy. Intern Med 2007, 46(1):49-53.
16. Klemmer P.J., Chalermskulrat W., Reif M.S., et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003, 42(6):1149-1153.
17. Savage C.O., Pusey C.D., Bowman C., et al. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J 1986, 292(6516):301-304.
18. Levy J.B., Turner A.N., Rees A.J., et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001, 134(11):1033-1042.
19. Ioachimescu O.C., Sieber S., Kotch A. Idiopathic pulmonary haemosiderosis revisited. Eur Respir J 2004, 24(1):162-169.
20. Kjellman B., Elinder G., Garwicz S., et al. Idiopathic pulmonary haemosiderosis in Swedish children. Acta Paediatr Scand 1984, 73(5):584-588.
21. Soergel K.H., Sommers S.C. Idiopathic pulmonary hemosiderosis and related syndromes. Am J Med 1962, 32(4):499-511.
22. Rubin G.D., Edwards D.K., Reicher M.A., et al. Diagnosis of pulmonary hemosiderosis by MR imaging. Am J Roentgenol 1989, 152(3):573-574.
23. Jeong Y.J., Kim K.I., Seo I.J., et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics 2007, 27(3):617-637.
24. Erzurum S.C., Underwood G.A., Hamilos D.L., et al. Pleural effusion in Churg-Strauss syndrome. Chest 1989, 95(6):1357-1359.
25. Guillevin L., Durand-Gasselin B., Cevallos R., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999, 42(3):421-430.
26. Lauque D., Cadranel J., Lazor R., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d[U+05F3]Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 2000, 79(4):222-233.
27. Betensley A.D., Yankaskas J.R. Factor VIIa for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med 2002, 166(9):1291-1292.
28. Swigris J.J., Fischer A., Gilles J., et al. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest 2008, 133:271-280.
29. Abud-Mendoza C., Diaz-Jouanen E., Alarcon-Segovia D. Fatal pulmonary hemorrhage in systemic lupus erythematosus: occurrence without hemoptysis. J Rheumatol 1985, 12:558-561.
30. Wiedemann H.P., Matthay R.A. Pulmonary manifestations of systemic lupus erythematosus. J Thorac Imaging 1992, 7(2):1-18.
31. Nihoyannopoulos P., Gomez P.M., Joshi J., et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990, 82(2):369-375.
32. Rosenbaum E., Krebs E., Cohen M., et al. The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review. Lupus 2009, 18(7):608-612.
33. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
34. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997, 40:1725.
35. Louie S., Gamble C.N., Cross C.E. Penicillamine associated pulmonary hemorrhage. J Rheumatol 1986, 13(5):963-966.
36. Haim D.Y., Lippmann M.L., Goldberg S.K., et al. The pulmonary complications of crack cocaine. A comprehensive review. Chest 1995, 107(1):233-240.
37. Murray R.J., Smialek J.E., Golle M., et al. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest 1989, 96:1050-1053.
38. Restrepo C.S., Carrillo J.A., Martínez S., et al. Pulmonary complications from cocaine and cocaine-based substances: imaging manifestations. Radiographics 2007, 27(4):941-956.
39. Afessa B., Tefferi A., Litzow M.R., et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002, 166(5):641-645.
40. Witte R.J., Gurney J.W., Robbins R.A., et al. Diffuse pulmonary alveolar hemorrhage after bone marrow transplantation: radiographic findings. Am J Roentgenol 1991, 157:461-464.
41. Metcalf J.P., Rennard S.I., Reed E.C., et al. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group. Am J Med 1994, 96(4):327-334.
42. Witte R.J., Gurney J.W., Robbins R.A., et al. Diffuse pulmonary alveolar hemorrhage after bone marrow transplantation: radiographic findings in 39 patients. Am J Roentgenol 1991, 157(3):461-464.
43. Frazier A.A., Galvin J.R., Franks T.J., et al. From the archives of the AFIP: pulmonary vasculature: hypertension and infarction. Radiographics 2000, 20(2):491-524.
44. Primack S.L., Miller R.R., Müller N.L. Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features. Am J Roentgenol 1995, 164(2):295-300.
45. Gupta S., Jain A., Warneke C.L., et al. Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007, 40(1):71-78.
46. Saeed M.M., Woo M.S., MacLaughlin E.F., et al. Prognosis in pediatric idiopathic pulmonary haemosiderosis. Chest 1999, 116(3):721-725.
47. Phillip R., Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008, 26(5 suppl 51):S94-S104.